2011-05-10T15:34:57-05:00 2010-09-30 LARSONALLEN LLP 2900 SOUTH QUINCY ST SUITE 150 ARLINGTON VA 22206 990 2009-10-01 362384118 American Association of Blood Banks AMER 3019076977 8101 Glenbrook Road Bethesda MD 20814 MARK R CONHEADY 3019076977 2011-05-04 1 Karen Gries 7039985100 2009 2016-02-24 21:20:13Z Karen Shoos Lipton 8101 Glenbrook Road Bethesda MD 20814 25338523 0 X www.aabb.org X 1958 IL To advance the practice and standards of transfusion medicine and cellular and related biological therapies. 19 19 101 250 803100 0 4928552 3380122 14057254 14628595 -196038 79270 2334563 1720795 21124331 19808782 26866 36627 0 9074594 9212192 137094 0 184275 12094183 10213556 21332737 19462375 -208406 346407 20206164 20351108 11508720 10850405 8697444 9500703 To advance the practice and standards of transfusion medicine and cellular and related biological therapies. 0 0 4768297 6907099 Education - American Association of Blood Banks provides educational programs including conferences, audio-conferences, publications, newsletters, and technical consulting services designed to provide continuing professional education to individuals in the field of transfusion medicine and cellular therapies. 5013767 7323082 Standards and Accreditation - American Association of Blood Banks develops standards and guidance for voluntary compliance and accreditation processes that define optimal patient and donor care in transfusion medicine and cellular therapies. 2458980 745274 Through its regulatory affairs and public policy programs, AABB provides information to members and the general public on federal government agency and legislative activities affecting transfusion and cellular therapies communities. Science and Research - American Association of Blood Banks advances the acquisition, translation and application of new knowledge in the disciplines of basic, clinical, behavioral, managerial and laboratory sciences as they apply to transfusion medicine, cellular and related biological therapies through its scholarly journal TRANSFUSION, providing data relevant to Blood supply, utilization, and diseases transmitted via blood and blood products. 641013 835805 National Blood Exchange Program 1841442 Government cooperative agreement and other contracts 2482455 835805 14723499 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 99 0 1 101 1 1 1 0 0 0 0 0 0 0 0 19 19 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR AZ LA KS KY MA MD ME MI MN MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV X Mark Conheady 2403336615 8101 Glenbrook Road Bethesda MD 20814 Jacquelyn Fredrick 10.00 X 0 0 0 Jay e Menitove MD 10.00 X 0 0 0 James P AuBuchon 10.00 X 0 0 0 James Chris Hrouda 10.00 X 0 0 0 Susan Stramer PhD 10.00 X 0 0 0 Susan Roseff MD 10.00 X 0 0 0 Donna Regan 10.00 X 0 0 0 Lynne Uhl MD 10.00 X 0 0 0 J Daniel Connor 10.00 X 0 0 0 Mary Beth Bassett 10.00 X 0 0 0 Thomas Lane MD 10.00 X 0 0 0 Silvano Wendel MD 10.00 X 0 0 0 Darrell J Triulzi MD 10.00 X 0 0 0 Jed Gorlin MD 10.00 X 0 0 0 Graham Sher MD 10.00 X 0 0 0 Jean Stanley 10.00 X 0 0 0 Dan Waxman MD 10.00 X 0 0 0 John D McMannis PhD 10.00 X 0 0 0 Robert Preti PhD 10.00 X 0 0 0 Karen Shoos Lipton JD 37.50 X 335501 0 34777 Mark Royal Conheady 37.50 X 152616 0 7428 Philip Schiff JD 37.50 X 202355 0 32223 Jean Otter 37.50 X 204461 0 27181 Michael Breard 37.50 X 167801 0 24933 Marc Pearce 37.50 X 197816 0 31929 James Reilly 37.50 X 191319 0 26263 Kathleen Loper 37.50 X 155853 0 23717 Barbee Whitaker 37.50 X 147334 0 28306 Diane Killion 37.50 X 137585 0 27811 shelley sullivan 37.50 X 121154 0 13170 Dennis Sadler 37.50 X 123198 0 25074 2136993 0 302812 19 0 1 0 David Mvere Flat 9 Harrison CT 10 Meyers Lane London UK Consulting, PEPFAR 472725 signature group 8229 Boone Blvd 820 Vienna VA 22182 IT Consulting 358092 aramark 800 West Katella Anaheim CA 92802 convention services 358092 BloodSource 10536 Peter A McCuen Blvd Mather CA 95655 Consulting, PEPFAR 264984 Rubino & Mcgeehan Chartered 6903 Rockledge Drive Bethesda MD 20817 Accounting Services 252570 23 2507381 872741 3380122 Dues 900099 7323082 7323082 Annual Meeting 541800 3474443 81780 3392663 Consulting 541900 1506689 1506689 National Blood Exchang 541900 835805 835805 Print/Online Publicati 541800 745274 178840 566434 743302 743302 14628595 301424 301424 362031 362031 892 892 892 892 5026352 5248506 -222154 -222154 -222154 1463900 281235 1182665 1182665 Service Fees 900003 154886 154886 Miscellaneous Income 900099 20321 20321 175207 19808782 11770383 803100 3855177 36627 36627 1857270 1071018 736593 49659 5795857 4361348 1392248 42261 429057 342226 85929 902 607537 429546 169717 8274 522471 363269 153005 6197 178332 98684 79648 81542 18676 62866 48000 48000 62688 62688 2500967 1820744 670184 10039 118331 117042 1289 726444 636609 88226 1609 495327 451528 42675 1124 743987 100100 643887 2088174 1896694 177149 14331 619800 594620 24758 422 6307 6307 749321 749321 390346 25315 365031 Training and Developmen 536116 504396 31720 Repairs and Maintenance 387648 112087 275561 General operating costs 229989 1512872 -1331010 48127 Marketing expenses 172465 171472 993 Miscellaneous Expenses 77772 58626 18809 337 19462375 14723499 4554601 184275 4539886 2675413 1025747 226025 454454 110954 3751167 3343376 374121 381133 865999 1099455 5817176 4001879 2206533 1815297 6839048 10545634 149209 153821 20206164 20351108 5472656 5010491 4901000 4981468 1135064 858446 11508720 10850405 X 7644177 8725628 1053267 775075 8697444 9500703 20206164 20351108 X 0 1 1 X 1 1 X 4230371 4946147 5759439 4928552 3380122 23244631 4230371 4946147 5759439 4928552 3380122 23244631 23244631 331972 794385 661737 891072 664347 3343513 549705 703064 769585 768773 803100 3594227 361660 62513 21291 18203 20321 483988 30666359 76755919 0.75800 0.76300 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 1 1 0 1 0 0 0 Part II-B, Line 1i: Explanation of Other Lobbying Activities: During FY 2010 the American Association of Blood Banks was interested in health related legislative initiatives affecting transfusion medicine and cellular therapies. American Association of Blood Banks developed positions on these issues and attempted to influence the legislation through direct contact and written communication with members of congress and their staff. American Association of Blood Banks' lobbying efforts focused primarily on appropriations for and authorization of blood safety initiatives in the President's emergency program for AIDS relief. The association also published articles about these issues in the association's newsletter. 598619 335097 263522 2037490 1759027 278463 3181067 1907755 1273312 1815297 Deferred lease incentive 261031 Deferred Rent 427002 Deferred Compensation Liability 119003 Capital lease 51410 858446 19808782 19462375 346407 456852 456852 803259 20546869 456852 281235 738087 19808782 0 19808782 19743610 281235 281235 19462375 0 19462375 Part XII, Line 2d - Other Adjustments: Cost of Goods Sold: 281235. Part XIII, Line 2d - Other Adjustments: Cost of Good Sold: 281235. 1 Sub-saharan Africa 6 program services standards & education training 2457381 North America Program Services Travel for accreditation services 25860 South America Program Services Travel for accreditation services 20029 Central America Program services Travel for accreditation services 3657 Europe Program Services Travel for accreditation services 20429 Middle East Program Services Travel for accreditation services 16484 South Asia Program Services Travel for accreditation services 1949 East Asia/Pacific Program Services Travel for accreditation services 16651 0 6 2562440 Method Used to Acccount for Expenditures: Schedule F, Part I, Line 3: All requests for funds relate to the management of the Pepfar. The cooperative agreement plan provides that certain activities will occur. From there, planning is made to ensure that the funds are going for the stated purpose. Expenses are then catalogued by country on a weekly basis and the report sent to the Director in charge of Pepfar to ensure that spending totals are kept within budgeted amounts under the cooperative agreement. All wires are requested by the Pepfar group. The wires are then initiated in Accounting and the funds tracked for timely submission of receipts. AABB has implemented a web based time and expense system, with scanned copies of all expenses submitted with the request for reimbursement. 1 The John Hopkins University 600 N Wolfe Street Carnegie 434 Baltimore MD 212876417 520595110 501(C)(3) 36627 TO FURTHER TRANSFUSION MEDICINE THROUGH RESEARCH IN THEIR TRANSFUSION LABS Procedure for Monitoring Grants in the U.S.: Part I, Line 2: Schedule I, Part I, Line 2: AABB PROVIDES AN ANNUAL GRANT TO JOHNS HOPKINS UNIVERSITY IN RECOGNITION OF SERVICES PROVIDED TO AABB'S JOURNAL, TRANSFUSION, BY PAUL NESS, MD, CHIEF OF TRANSFUSION MEDICINE. THE GRANT IS USED TO FURTHER TRANSFUSION MEDICINE THROUGH RESEARCH IN JHU's TRANSFUSION LABS. DR. NESS SERVES AS EDITOR-IN-CHIEF OF THE JOURNAL. THE BOARD OF DIRECTORS AWARDED THE GRANT TO JOHNS HOPKINS UNIVERSITY IN RECOGNITION OF DR. NESS's VOLUNTARY CONTRIBUTION, BASED ON DR. NESS's UNIQUE QUALIFICATIONS AS A PHYSICIAN WITH A SPECIALTY IN TRANSFUSION MEDICINE, HIS KNOWLEDGE OF National AND INTERNATIONAL ISSUES RELATING TO TRANSFUSION MEDICINE, AND HIS MULTIPLE YEARS OF SERVICE AS A VOLUNTEER ASSOCIATE EDITOR FOR THE JOURNAL PRIOR TO BECOMING THE EDITOR-IN-CHIEF. X X X X 0 0 0 0 0 0 0 0 0 Karen Shoos Lipton JD 335501 0 0 0 0 0 19584 0 15193 0 370278 0 0 0 Mark Royal Conheady 152616 0 0 0 0 0 0 0 7428 0 160044 0 0 0 Philip Schiff JD 192635 0 9720 0 0 0 12040 0 20183 0 234578 0 0 0 Jean Otter 194453 0 10008 0 0 0 12169 0 15012 0 231642 0 0 0 Michael Breard 159174 0 8627 0 0 0 10156 0 14777 0 192734 0 0 0 Marc Pearce 191484 0 6332 0 0 0 11683 0 20246 0 229745 0 0 0 James Reilly 184567 0 6752 0 0 0 11334 0 14929 0 217582 0 0 0 Kathleen Loper 150284 0 5569 0 0 0 9231 0 14486 0 179570 0 0 0 Barbee Whitaker 143100 0 4234 0 0 0 8705 0 19601 0 175640 0 0 0 Diane Killion 134268 0 3317 0 0 0 8115 0 19696 0 165396 0 0 0 Janis Schiff family member of Philip Schiff, key employee 106685 managing partner of independent contractor, Holland & Knight 0 Form 990, Part VI, Section A, line 1 The Executive Committee of the Board is comprised of the president, vice president, secretary/treasurer, president-elect, immediate past president and the CEO. The Executive Committee shall conduct all necessary business of the organization in the interim between the sessions of the Board, and shall report the results of its meetings, deliberations, and other actions to the Board in a timely manner. Form 990, Part VI, Section A, line 6 The organization has two classes of members, institutional and individual. Form 990, Part VI, Section A, line 7a All members vote for the Board of Directors in the annual business meeting. Those candidates are normally proposed by the Nominating Committee. Members are free to accept or reject the candidates proposed. Form 990, Part VI, Section A, line 7b The issues decided upon by the board of directors and Executive Council are not submitted to the members for approval, though all changes to Bylaws and governing documents must be approved by the members at the annual business meeting, which is held in conjunction with the annual meeting. Form 990, Part VI, Section B, line 11 The Audit and Ethics Committee will meet and review the 990 tax return and after that will present the action taken as a report of the Committee to the full Board at its next regularly scheduled meeting. Form 990, Part VI, Section B, line 12c American Association of Blood Banks has developed a disclosure policy, which is to be completed annually and updated whenever necessary to disclose new conflicts by board members, those appointed to serve on committees and all staff. Volunteer assessors are required to complete and keep current a separate form developed by the Accreditation Department. The Executive Office and the Human Resources department ensure that conflicts of interest (e.g., grants or contract support, consultancies, board positions) of board members, committee members (including representatives) and staff that present an actual or apparent conflict of interest are disclosed annually in writing and updated whenever necessary to disclose new conflicts. Changes in such conflicts are reflected on disclosure forms provided at every board and committee meeting. Once a conflict has been disclosed, the president or the committee chair, as applicable, on his or her own initiative or at the request of a board or committee member, has the authority to require that the conflicted individual be recused from discussing and/or voting on the particular issue. Form 990, Part VI, Section B, line 15 At least every two years, a compensation and benefits specialist reviews all jobs and job descriptions and ensures that the salary range for each job is competitive with market conditions. The American Association of Blood Banks' Human Resources committee annually reviews the compensation of officers and key employees. The process was last undertaken in February 2010 for the CEO and other officers/key employees. Form 990, Part VI, Section C, line 19 The organization's governing documents and conflict of interest policy are available on the organization's website. National Blood Foundation Research and Education Trust 8101 Glenbrook Rd Bethesda MD 20814 522059102 To fund research, education and training MD 501(c)(3) 11a - Type 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 National Blood Foundation Research and Education Trust K 154886